HOME >> BIOLOGY >> NEWS
Muscle derived cell transplants offer alternative incontinence therapy says Pitt study

ORLANDO, May 25 Researchers from the University of Pittsburgh School of Medicine have found that, in animal models, autologous skeletal muscle derived cell (MDC) transplants offer a safer, more effective and longer lasting treatment for urinary incontinence than existing methods. In the procedure, muscle cells are taken from the individual, purified and cloned, and then reinjected into the bladder.

In patients who need more advanced treatments for incontinence, we currently have the options of treating them through surgery or through the injection of bulking agents like collagen. Although collagen injections give good short-term results and are less invasive than surgery, there is a possibility of the collagen being reabsorbed or causing allergic reactions, said Ryan J. Pruchnic, of the departments of urology and orthopaedic surgery, University of Pittsburgh School of Medicine and lead author of the study. In our study, MDCs have the potential to offer a longer-term solution without the risk of rejection.

Pruchnic and colleagues presented these findings today at the Centennial Celebration Annual Meeting of the American Urological Association (AUA). Results are published in abstract 131 in the AUA proceedings.

In the study, researchers obtained a mixed population of MDCs from a mouse skeletal muscle biopsy. The cells were purified to obtain a population that was purely myogenic meaning that the cells were from muscle and capable of producing muscle. One cell from this population was then genetically engineered and cloned to form a large population. These cells were then injected into the bladder walls of mice.

The bladders of the mice were evaluated at one, four and eight weeks and 6 months. On evaluation, researchers noted the presence of myofibers, or differentiated muscle cells, throughout the smooth muscle layer, the number of which did not significantly decrease over time. Some of the myofibers expressed a-smooth muscle ac
'"/>

Contact: Jocelyn Uhl
412-647-3555
University of Pittsburgh Medical Center
25-May-2002


Page: 1 2

Related biology news :

1. Muscles are smarter than you think
2. Muscle-derived cells and gene therapy may cure for post-prostatectomy erectile dysfunction
3. Muscle protein has role in nerve disorders
4. Muscle-repair defect underlies two muscular dystrophies
5. Muscle gene influences fat storage in mice; may be target to prevent or treat obesity and diabetes
6. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant
7. Common Respiratory Virus Identified As One Cause Of Heart Muscle Damage That Can Lead To Sudden Death
8. Technique Measures Muscle Contraction At Molecular Level
9. Growth Factors Improve Muscle Healing In Animals
10. Skeletal Muscle Yields Precursors Of Bone Cells That Form Bone When Transplanted Into Animals
11. New Gene Therapy Strategy Keeps Muscles Strong In Old Age: Possibilities Seen For Disease Treatment, But Also For Athletic Or Cosmetic Enhancements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
Breaking Biology Technology:
Cached News: